首页> 外文期刊>PharmacoEconomics >Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models
【24h】

Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models

机译:透明不确定性评估(信托)工具评估卫生经济决策模型的不确定性的开发和验证

获取原文
获取原文并翻译 | 示例
           

摘要

Background An increasing number of technologies are obtaining marketing authorisation based on sparse evidence, which causes growing uncertainty and risk within health technology reimbursement decision making. To ensure that uncertainty is considered and addressed within health technology assessment (HTA) recommendations, uncertainties need to be identified, included in health economic models, and reported. Objective Our objective was to develop the TRansparent Uncertainty ASsessmenT (TRUST) tool for systematically identifying, assessing, and reporting uncertainties in decision models, with the aim of making uncertainties and their impact on cost effectiveness more explicit and transparent. Methods TRUST was developed by drawing on the uncertainty and risk assessment literature. To develop and validate this tool, we conducted HTA stakeholder discussion meetings and interviews and applied it in six real-world HTA case studies in the Netherlands and the UK. Results The TRUST tool enables the identification and categorisation of uncertainty according to its source (transparency issues, methodology issues, and issues with evidence: imprecision, bias and indirectness, and unavailability) in each model aspect. The source of uncertainty determines the appropriate analysis. The impact of uncertainties on cost effectiveness is also assessed. Stakeholders found using the tool to be feasible and of value for transparent uncertainty assessment. TRUST can be used during model development and/or model review. Conclusion The TRUST tool enables systematic identification, assessment, and reporting of uncertainties in health economic models and may contribute to more informed and transparent decision making in the face of uncertainty.
机译:背景技术越来越多的技术正在基于稀疏证据获得营销授权,这导致健康技术报销决策中的不确定性和风险越来越大。为确保在卫生技术评估(HTA)中考虑并解决了不确定性,建议,需要确定不确定性,包括在卫生经济模式中,并报告。目的是我们的目标是制定透明的不确定性评估(信托)工具,以系统地识别,评估和报告决策模式的不确定性,目的是要使不确定性及其对成本效益的影响更明确和透明。方法是通过绘制不确定性和风险评估文学制定的信任。要开发和验证此工具,我们开展了HTA利益相关方讨论会议和访谈,并在荷兰和英国的六个现实世界HTA案例研究中应用。结果,信任工具可以根据其源(透明度问题,方法问题,以及证据:不精确,偏见和间接和不可用的问题进行识别和分类,在每个模型方面都有。不确定性的来源决定了适当的分析。还评估了不确定性对成本效益的影响。利益相关者发现使用该工具是可行的和价值的透明不确定性评估。信任可以在模型开发和/或模型审查期间使用。结论信托工具能够系统的识别,评估和报告卫生经济模式的不确定性,并可能有助于面对不确定性的更明智和透明的决策。

著录项

  • 来源
    《PharmacoEconomics》 |2020年第2期|共12页
  • 作者单位

    Maastricht Univ Med Ctr Dept Clin Epidemiol &

    Med Technol Assessment Sch Publ Hlth &

    Primary;

    Maastricht Univ Med Ctr Dept Clin Epidemiol &

    Med Technol Assessment Sch Publ Hlth &

    Primary;

    Maastricht Univ Med Ctr Dept Clin Epidemiol &

    Med Technol Assessment Sch Publ Hlth &

    Primary;

    Maastricht Univ Med Ctr Dept Clin Epidemiol &

    Med Technol Assessment Sch Publ Hlth &

    Primary;

    Zorginst Nederland Willem Dudokhof 1 NL-1112 ZA Diemen Netherlands;

    Radboud Univ Nijmegen Med Ctr Dept Hlth Evidence Post 133 POB 9101 NL-6500 HB Nijmegen;

    Maastricht Univ Med Ctr Dept Clin Epidemiol &

    Med Technol Assessment Sch Publ Hlth &

    Primary;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号